Sana Biotechnology slides after $75 mln equity offering
** Sana Biotechnology's SANA.O shares down 12.7% premarket to $3.71 after $75 mln overnight follow-on priced
** Seattle, Washington-based firm late Weds announced ~22.4 mln shares, including ~1.5 mln p re-funded warrants
** Offering price of $3.35 represents 18.5% discount to stock's last sale
** Co, which develops engineered cells to treat diseases, plans to use net offering proceeds to support its preclinical and most advanced product candidates, per the prospectus
** Morgan Stanley, Goldman Sachs, BofA and TD Cowen are joint bookrunners for the offering
** With ~225.5 mln shares outstanding, co has roughly $960 mln market cap
** SANA shares on Weds edged down 0.2%, trimming YTD gain to 161%
** 6 of 7 analysts rate SANA "strong buy" or "buy", and 1 has "hold" rating and median PT is $9, LSEG data reflects
Related Articles
Sea 2Q25 Earnings Preview: Shopee is Still Rocking?
TradingKey - Sea Limited will release its earnings for the second quarter of the fiscal 2025 on August 12th before the bell.
BoE August Rate Decision Commentary: Where Next for the Pound?
TradingKey - On 7 August 2025, the Bank of England (BoE) lowered its benchmark interest rate from 4.25% to 4%, aligning with broad market expectations. Notably, the decision sparked significant division within the committee, requiring two rounds of voting to pass.
MP Materials 2Q25 Earnings Comment: Going up the Value Chain
TradingKey - MP Materials released its earnings for the second quarter of the fiscal 2025 on August 7th after the bell.The smaller loss and the better revenue were surely welcomed by investors, and the stock is up 8.50% in the post-bell session.
Eli Lilly’s Q2 2025 Triumph: Soaring Revenue, Plunging Stock – What’s Behind the Paradox?
TradingKey - Eli Lilly released its Q2 2025 financial results, demonstrating impressive financial performance. However, despite the stellar results, its stock price plummeted by over 14%, closing at approximately $640, down more than 30% from its yearly high..jpg)
Caution on Short-Term Downside Risks for U.S. Stock Market
TradingKey - Last Friday, the U.S. Labor Department sharply revised downward its May and June nonfarm payroll figures by a combined 258,000 jobs, a reduction exceeding 90%. Meanwhile, July’s payroll increase came in at just 73,000, falling short of the 100,000 forecast.
